BeOne Medicines - Gross Profit 2014-2025 | ONC

BeOne Medicines - annual/quarterly gross profit history and growth rate from 2014 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.

BeOne Medicines - gross profit for the quarter ending September 30, 2025 was $1.216B, a 46.28% increase year-over-year.
BeOne Medicines - gross profit for the twelve months ending September 30, 2025 was $4.286B, a 54.31% increase year-over-year.
BeOne Medicines - annual gross profit for 2024 was $3.216B, a 54.71% increase from 2023.
BeOne Medicines - annual gross profit for 2023 was $2.079B, a 84.06% increase from 2022.
BeOne Medicines - annual gross profit for 2022 was $1.129B, a 11.67% increase from 2021.

BeOne Medicines - Annual Gross Profit (Millions of US $)
2024	$3,216
2023	$2,079
2022	$1,129
2021	$1,011
2020	$238
2019	$357
2018	$170
2017	$233
2016	$1
2015	$9
2014	$13
2013	$11

BeOne Medicines - Quarterly Gross Profit (Millions of US $)
2025-09-30	$1,216
2025-06-30	$1,151
2025-03-31	$952
2024-12-31	$967
2024-09-30	$831
2024-06-30	$791
2024-03-31	$627
2023-12-31	$529
2023-09-30	$685
2023-06-30	$499
2023-03-31	$366
2022-12-31	$307
2022-09-30	$311
2022-06-30	$270
2022-03-31	$241
2021-12-31	$165
2021-09-30	$159
2021-06-30	$114
2021-03-31	$573
2020-12-31	$79
2020-09-30	$70
2020-06-30	$51
2020-03-31	$38
2019-12-31	$39
2019-09-30	$30
2019-06-30	$226
2019-03-31	$63
2018-12-31	$49
2018-09-30	$45
2018-06-30	$47
2018-03-31	$28
2017-12-31	$15
2017-09-30	$218
2017-06-30
2017-03-31
2016-12-31	$0
2016-09-30
2016-06-30	$0
2016-03-31	$1
2015-12-31	$5
2015-09-30
2015-06-30	$1
2015-03-31	$1
2014-12-31
2013-12-31

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$38.812B	$3.810B
BeOne Medicines is an oncology company which involved in discovering and developing treatments to cancer patients. BeOne Medicines, formerly known as BeiGene Ltd., is based in SAN CARLOS, Calif.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$92.346B	32.25
Takeda Pharmaceutical (TAK)	Japan	$56.926B	11.18
Zoetis (ZTS)	United States	$56.153B	20.10
Sandoz Group AG (SDZNY)	Switzerland	$35.065B	0.00
Daiichi Sankyo, - (DSNKY)	Japan	$34.401B	0.00
United Therapeutics (UTHR)	United States	$20.898B	18.39
Merck (MKKGY)	Germany	$18.714B	11.54
Shionogi (SGIOY)	Japan	$18.571B	14.36
Neurocrine Biosciences (NBIX)	United States	$14.078B	33.78
Ionis Pharmaceuticals (IONS)	United States	$14.011B	0.00
IPSEN (IPSEY)	France	$13.491B	0.00
Summit Therapeutics (SMMT)	United States	$11.560B	0.00
Orion OYJ (ORINY)	Finland	$11.502B	32.86
Madrigal Pharmaceuticals (MDGL)	United States	$10.847B	0.00
Eisai (ESAIY)		$8.574B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$7.149B	17.10
Stevanato Group S.p.A (STVN)	Italy	$4.694B	26.27
Crinetics Pharmaceuticals (CRNX)	United States	$4.626B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.591B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.565B	21.67
Indivior Pharmaceuticals (INDV)	United States	$4.296B	17.53
Corcept Therapeutics (CORT)	United States	$4.295B	46.40
NewAmsterdam Pharma (NAMS)	Netherlands	$3.889B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.158B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$3.004B	9.58
Hypermarcas (HYPMY)	Brazil	$2.755B	18.91
Dyne Therapeutics (DYN)	United States	$2.399B	0.00
Soleno Therapeutics (SLNO)	United States	$2.231B	0.00
Guardian Pharmacy Services (GRDN)	United States	$2.145B	41.32
Avadel Pharmaceuticals (AVDL)	Ireland	$2.118B	0.00
Ocular Therapeutix (OCUL)	United States	$1.994B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.904B	22.56
Ardelyx (ARDX)	United States	$1.779B	0.00
Harrow (HROW)	United States	$1.753B	107.54
Enliven Therapeutics (ELVN)	United States	$1.746B	0.00
Definium Therapeutics (DFTX)	United States	$1.665B	0.00
Oruka Therapeutics (ORKA)	United States	$1.600B	0.00
Relay Therapeutics (RLAY)	United States	$1.546B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.535B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.505B	7.45
BioCryst Pharmaceuticals (BCRX)	United States	$1.345B	79.75
Evotec AG (EVO)	Germany	$1.254B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.163B	0.00
Savara (SVRA)	United States	$1.078B	0.00
Theravance Biopharma (TBPH)	United States	$1.038B	43.57
Cronos Group (CRON)	Canada	$1.004B	0.00
ARS Pharmaceuticals (SPRY)	United States	$0.991B	0.00
Aktis Oncology (AKTS)	United States	$0.961B	0.00
Xencor (XNCR)	United States	$0.829B	0.00
Esperion Therapeutics (ESPR)	United States	$0.813B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.753B	0.00
Nektar Therapeutics (NKTR)	United States	$0.749B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.742B	17.54
Bioventus (BVS)	United States	$0.704B	14.42
Rigel Pharmaceuticals (RIGL)	United States	$0.620B	5.53
ProKidney (PROK)	United States	$0.563B	0.00
Altimmune (ALT)	United States	$0.550B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.523B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.514B	0.00
Aquestive Therapeutics (AQST)	United States	$0.501B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.484B	0.00
Lyell Immunopharma (LYEL)	United States	$0.482B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.481B	0.00
Siga Technologies (SIGA)	United States	$0.480B	6.57
Organogenesis (ORGO)	United States	$0.478B	0.00
Nature's Sunshine Products (NATR)	United States	$0.461B	27.43
USANA Health Sciences (USNA)	United States	$0.390B	10.89
Aclaris Therapeutics (ACRS)	United States	$0.387B	0.00
Akebia Therapeutics (AKBA)	United States	$0.369B	0.00
Protara Therapeutics (TARA)	United States	$0.343B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.333B	0.00
Cybin (HELP)	Canada	$0.298B	0.00
Relmada Therapeutics (RLMD)	United States	$0.285B	0.00
Larimar Therapeutics (LRMR)	United States	$0.279B	0.00
Journey Medical (DERM)	United States	$0.278B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.275B	0.00
Avalo Therapeutics (AVTX)	United States	$0.263B	0.00
OmniAb (OABI)	United States	$0.245B	0.00
Profound Medical (PROF)	Canada	$0.236B	0.00
Heron Therapeutics (HRTX)	United States	$0.231B	0.00
MediWound (MDWD)	Israel	$0.228B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.226B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.224B	0.00
Context Therapeutics (CNTX)	United States	$0.209B	0.00
Minerva Neurosciences (NERV)	United States	$0.208B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.199B	0.00
Surrozen (SRZN)	United States	$0.195B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Galectin Therapeutics (GALT)	United States	$0.181B	0.00
AleAnna (ANNA)	United States	$0.179B	0.00
Century Therapeutics (IPSC)	United States	$0.149B	0.00
VAXART, INC (VXRT)	United States	$0.146B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.144B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.137B	0.00
Prelude Therapeutics (PRLD)	United States	$0.136B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.128B	0.00
Avita Medical (RCEL)	United States	$0.119B	0.00
Korro Bio (KRRO)	United States	$0.118B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.115B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.111B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.110B	0.00
Incannex Healthcare (IXHL)	Australia	$0.100B	0.00
Vivani Medical (VANI)	United States	$0.098B	0.00
Cassava Sciences (SAVA)	United States	$0.098B	0.00
Pyxis Oncology (PYXS)	United States	$0.094B	0.00
Champions Oncology (CSBR)	United States	$0.091B	38.53
Assertio Holdings (ASRT)	United States	$0.082B	0.00
PolyPid (PYPD)	Israel	$0.072B	0.00
HST Global (HSTC)	United States	$0.069B	0.00
Gain Therapeutics (GANX)	United States	$0.067B	0.00
Rafael Holdings (RFL)	United States	$0.063B	0.00
Dominari Holdings (DOMH)	United States	$0.061B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.058B	48.88
Procaps Group, S.A (PROCF)	Luxembourg	$0.058B	0.00
Fractyl Health (GUTS)	United States	$0.057B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.057B	0.00
BioNxt Solutions (BNXTF)	Canada	$0.056B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.055B	0.00
Nutriband (NTRB)	United States	$0.053B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.053B	0.00
Liminatus Pharma (LIMN)	United States	$0.050B	0.00
Lipocine (LPCN)	United States	$0.047B	0.00
ElectroCore (ECOR)	United States	$0.044B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.040B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Lite Strategy (LITS)	United States	$0.039B	0.00
Talphera (TLPH)	United States	$0.038B	0.00
Plus Therapeutics (PSTV)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.033B	0.00
SCYNEXIS (SCYX)	United States	$0.032B	0.00
Wellgistics Health (WGRX)	United States	$0.028B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.028B	0.00
TherapeuticsMD (TXMD)	United States	$0.027B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.021B	0.00
Natural Alternatives (NAII)	United States	$0.020B	0.00
Scienture Holdings (SCNX)	United States	$0.019B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Klotho Neurosciences (KLTO)	United States	$0.018B	0.00
Cosmos Health (COSM)	United States	$0.017B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.016B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.016B	0.00
Traws Pharma (TRAW)	United States	$0.016B	0.02
Vyome Holdings (HIND)	United States	$0.015B	0.00
Vivos Therapeutics (VVOS)	United States	$0.015B	0.00
Inotiv (NOTV)	United States	$0.014B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
Tempest Therapeutics (TPST)	United States	$0.012B	0.00
CASI Pharmaceuticals (CASI)	China	$0.011B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.008B	0.00
Nuvilex (PMCB)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.007B	0.00
Mangoceuticals (MGRX)	United States	$0.006B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.006B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.005B	0.00
Heatwurx (PCSA)	United States	$0.005B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.005B	0.00
Aptorum Group (APM)	United Kingdom	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.004B	0.00
Indaptus Therapeutics (INDP)	United States	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.003B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.003B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.003B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
SciSparc (SPRC)	Israel	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
Clearmind Medicine (CMND)	Canada	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.000B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
PainReform (PRFX)	Israel	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00